Cargando…

Analysis of risk factors for determining the need for prostate biopsy in patients with negative MRI

To analyze the clinical characteristics of patients with negative biparametric magnetic resonance imaging (bpMRI) who didn’t need prostate biopsies (PBs). A total of 1,012 male patients who underwent PBs in the First Affiliated Hospital of Nanjing Medical University from March 2018 to November 2019,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Linghui, Qi, Feng, Cheng, Yifei, Zhang, Lei, Cao, Dongliang, Cheng, Gong, Hua, Lixin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960992/ https://www.ncbi.nlm.nih.gov/pubmed/33723287 http://dx.doi.org/10.1038/s41598-021-83802-z

Ejemplares similares

Association study between genetic variants in retinol metabolism pathway genes and prostate cancer risk
por: Cao, Dongliang, et al.
Publicado: (2020)

Predictors of clinically significant prostate cancer in biopsy-naïve and prior negative biopsy men with a negative prostate MRI: improving MRI-based screening with a novel risk calculator
por: van Riel, Luigi A.M.J.G., et al.
Publicado: (2022)

A prostate biopsy strategy based on a new clinical nomogram reduces the number of biopsy cores required in high-risk patients
por: Huang, Yuan, et al.
Publicado: (2014)

High-risk prostate cancer: value of multi-modality 3T MRI-guided biopsies after previous negative biopsies
por: Fütterer, Jurgen J., et al.
Publicado: (2011)

Characteristics of prostate cancer detection rate (PCDR) in Chinese Han population under different prostate biopsy methods
por: Pan, Yongsheng, et al.
Publicado: (2017)

Is Additional Systematic Biopsy Necessary in All Initial Prostate Biopsy Patients With Abnormal MRI?
por: Cheng, Xueqing, et al.
Publicado: (2021)

MRI-targeted biopsy cores from prostate index lesions: assessment and prediction of the number needed
por: Beetz, Nick Lasse, et al.
Publicado: (2022)

Repeat Prostate Biopsy Strategies after Initial Negative Biopsy: Meta-Regression Comparing Cancer Detection of Transperineal, Transrectal Saturation and MRI Guided Biopsy
por: Nelson, Adam W., et al.
Publicado: (2013)

MRI Screening and MRI/US Fusion-Guided Transperineal Biopsy in Detecting Prostate Cancer
por: Yin, Hongqing, et al.
Publicado: (2021)

Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies
por: Lantz, Anna, et al.
Publicado: (2020)

Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy
por: Vėželis, Alvydas, et al.
Publicado: (2021)

bpMRI and mpMRI for detecting prostate cancer: A retrospective cohort study
por: Pan, Yongsheng, et al.
Publicado: (2023)

Comparison of clinically significant prostate cancer detection by MRI cognitive biopsy and in-bore MRI-targeted biopsy for naïve biopsy patients
por: Zhang, Kai, et al.
Publicado: (2020)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
por: Lee, Kwang Suk, et al.
Publicado: (2017)

Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies
por: Sheikh, Nissar, et al.
Publicado: (2016)

Comparison of MRI/US Fusion Targeted Biopsy and Systematic Biopsy in Biopsy-Naïve Prostate Patients with Elevated Prostate-Specific Antigen: A Diagnostic Study
por: Huang, Chen, et al.
Publicado: (2022)

Diagnostic Accuracy of Robot-Guided, Software Based Transperineal MRI/TRUS Fusion Biopsy of the Prostate in a High Risk Population of Previously Biopsy Negative Men
por: Kroenig, Malte, et al.
Publicado: (2016)

The Clinical Value of Performing an MRI before Prostate Biopsy
por: Choi, Myung Sun, et al.
Publicado: (2011)

MRI-targeted prostate biopsy: the next step forward!
por: Cata, Emanuel Darius, et al.
Publicado: (2021)

A prostate biopsy risk calculator based on MRI: development and comparison of the Prospective Loyola University multiparametric MRI (PLUM) and Prostate Biopsy Collaborative Group (PBCG) risk calculators
por: Patel, Hiten D., et al.
Publicado: (2022)

Cost-effectiveness of MRI targeted biopsy strategies for diagnosing prostate cancer in Singapore
por: Cheng, Li-Jen, et al.
Publicado: (2021)

Does experience change the role of systematic biopsy during MRI-fusion biopsy of the prostate?
por: Jahnen, Matthias, et al.
Publicado: (2023)

Targeted 11C–choline PET-CT/TRUS software fusion-guided prostate biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy
por: Lazzeri, Massimo, et al.
Publicado: (2017)

Prostate Biopsy: What is the future of this old Procedure? The Multiparametric Magnetic Resonance Imaging MRI/TRUS fusion prostate biopsy
Publicado: (2015)

Association of multiparametric MRI quantitative imaging features with prostate cancer gene expression in MRI-targeted prostate biopsies
por: Stoyanova, Radka, et al.
Publicado: (2016)

Outcomes of combination MRI-targeted and transperineal template biopsy in restaging low-risk prostate cancer for active surveillance
por: Chen, Kenneth, et al.
Publicado: (2018)

Multiparametric MRI in Biopsy Guidance for Prostate Cancer: Fusion-Guided
por: Rothwax, Jason T., et al.
Publicado: (2014)

MRI-guided biopsies and minimally invasive therapy for prostate cancer
por: Ghai, Sangeet, et al.
Publicado: (2015)

A critical comparison of techniques for MRI-targeted biopsy of the prostate
por: Giganti, Francesco, et al.
Publicado: (2017)

MRI-Targeted Prostate Biopsy: What Radiologists Should Know
por: Das, Chandan J, et al.
Publicado: (2020)

Developing a Follow-Up Strategy for Patients with PSA Ranging from 4 to 10 ng/ml via a New Model to Reduce Unnecessary Prostate Biopsies
por: Zhao, Ruizhe, et al.
Publicado: (2014)

Is contrast enhancement needed for diagnostic prostate MRI?
por: Scialpi, Michele, et al.
Publicado: (2017)

Multiparametric Prostate MRI in Biopsy-Naïve Men: A Prospective Evaluation of Performance and Biopsy Strategies
por: Krüger-Stokke, Brage, et al.
Publicado: (2021)

Can we omit systematic biopsies in patients undergoing MRI fusion-targeted prostate biopsies?
por: Leow, Jeffrey J, et al.
Publicado: (2022)

Prediction of prostate cancer Gleason score upgrading from biopsy to radical prostatectomy using pre-biopsy multiparametric MRI PIRADS scoring system
por: Alqahtani, Saeed, et al.
Publicado: (2020)

Prevalence and risk factors for incidental prostate cancer in patients after transurethral resection of the prostate with negative results on prostate biopsy: A retrospective study
por: Guo, Zhenlang, et al.
Publicado: (2022)

Cost-Effectiveness of Annual Prostate MRI and Potential MRI-Guided Biopsy After Prostate-Specific Antigen Test Results
por: Yun, Hyunkyung, et al.
Publicado: (2023)

Development of a Nuclear Morphometric Signature for Prostate Cancer Risk in Negative Biopsies
por: Gann, Peter H., et al.
Publicado: (2013)

Risk of progression following a negative biopsy in prostate cancer active surveillance
por: Beckmann, Kerri, et al.
Publicado: (2022)

Repeat Targeted Prostate Biopsy under Guidance of Multiparametric MRI-Correlated Real-Time Contrast-Enhanced Ultrasound for Patients with Previous Negative Biopsy and Elevated Prostate-Specific Antigen: A Prospective Study
por: Jang, Dong Ryul, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3pki0rc6mfpn0p8utfbg1boj0i